Minimal residual disease: a target for radioimmunotherapy with 131I-labeled monoclonal antibodies? Some dosimetric considerations

Minimal residual disease: a target for radioimmunotherapy with 131I-labeled monoclonal antibodies? Some dosimetric considerations

Saved in:
Bibliographic Details
Published in:Recent results in cancer research Vol. 141; p. 67
Main Authors: Sautter-Bihl, M L, Herbold, G, Bihl, H
Format: Journal Article
Language:English
Published: Germany 1996
Subjects:
Absorption
Antibodies, Monoclonal - pharmacokinetics
Antibodies, Monoclonal - therapeutic use
Computer Simulation
Energy Transfer
Humans
Immunoconjugates - pharmacokinetics
Immunoconjugates - therapeutic use
Iodine Radioisotopes - pharmacokinetics
Iodine Radioisotopes - therapeutic use
Models, Biological
Monte Carlo Method
Neoplasm, Residual - radiotherapy
Phantoms, Imaging
Radioimmunotherapy
Radiotherapy Dosage
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0080-0015
DOI:10.1007/978-3-642-79952-5_5